The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical characteristics of nonosteogenic, non-Ewing’s sarcoma of the bone: Experience at the Toronto Sarcoma Program.
 
Zachary William Neil Veitch
No Relationships to Disclose
 
Peter Charles Ferguson
No Relationships to Disclose
 
Anthony Griffin
No Relationships to Disclose
 
Kanan Alshammari
No Relationships to Disclose
 
Esmail Mutahar Al-Ezzi
No Relationships to Disclose
 
Eoghan Ruadh Malone
No Relationships to Disclose
 
Elizabeth Demicco
Consulting or Advisory Role - Bayer
 
Brendan Dickson
No Relationships to Disclose
 
Charles N. Catton
Honoraria - Sanofi
Consulting or Advisory Role - Abbvie; Bayer; Janssen Oncology; Sanofi
Research Funding - Abbvie (Inst)
 
Peter W. M. Chung
Honoraria - Abbvie; AstraZeneca
Research Funding - Abbvie
 
Abha A. Gupta
No Relationships to Disclose
 
Albiruni Ryan Abdul Razak
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Merck
Research Funding - Abbvie; Adaptimmune; Amgen; Blueprint Medicines; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; CASI Pharmaceuticals; Deciphera; GlaxoSmithKline; Karyopharm Therapeutics; Lilly; MedImmune; Merck; Novartis; Pfizer; Roche/Genentech
 
Jay Wunder
No Relationships to Disclose